Dissertations / Theses on the topic 'Proteine non histone'

Thesis (M.S.)--West Virginia University, 2007.
Title from document title page. Document formatted into pages; contains vii, 124 p. : ill. (some col.). Includes abstract. Includes bibliographical references (p. 116-124).

Les protistes dinoflagelles (pyrrhophytes) representent la seule classe d'eucaryotes dont la chromatine est depourvue d'histones et de nucleosomes. Les proteines nucleaires basiques ont ete caracterisees et leurs proprietes dna-binding demontrees in vivo et in vitro chez l'espece crythecodinium cohnii. La famille des proteines hcc de 14kda qui represente environ 30% de proteines basiques a ete plus particulierement analysee. La fabrication et la purification d'un anticorps polyclonal dirige contre hcca permis d'isoler des clones de cdna codant pour cette proteine a partir d'une banque d'expression. L'analyse de leur sequence nucleotidique a revele deux variants presentent une homologie de 77%. Les proteines hcc ont ete immunolocalises sur coupes, en microscopie optique et electronique. Elles sont detectees preferentiellement a la peripherique des chromosomes et dans la nucleole. Cette localisation dans des regions activement transcrites suggere que les proteines basiques hcc, dont la fonction n'est pas encore connue, pourraient intervenir dans les premiers stades de l'expression genetique ou dans l'organisation de la chromatine active

Cell growth and proliferation are processes in the cell that must be tightly regulated. Transcription of ribosomal RNA and ribosomal biogenesis are directly linked to cell growth and proliferation, since the ribosomal RNA encodes for the majority of transcription in a cell and ribosomal biogenesis influences directly the number of proteins that are synthesized. In the work presented in this thesis, we have investigated the ribosomal RNA genes, namely the ribosomal DNA genes and the 5S rRNA genes, and their transcriptional regulation. One protein complex that is involved in RNA polymerase I and III transcription is the chromatin remodelling complex B‑WICH (WSTF, SNF2h, NM1). RNA polymerase I transcribes the rDNA gene, while RNA polymerase III transcribes the 5S rRNA gene, among others. In Study I we determined the mechanism by which B‑WICH is involved in regulating RNA polymerase I transcription. B‑WICH is associated with the rDNA gene and was able to create a more open chromatin structure, thereby facilitating the binding of HATs and the subsequent histone acetylation. This resulted in a more active transcription of the ribosomal DNA gene. In Study II we wanted to specify the role of NM1 in RNA polymerase I transcription. We found that NM1 is not capable of remodelling chromatin in the same way as B‑WICH, but we demonstrated also that NM1 is needed for active RNA polymerase I transcription and is able to attract the HAT PCAF. In Study III we investigated the intergenic part of the ribosomal DNA gene. We detected non-coding RNAs transcribed from the intergenic region that are transcribed by different RNA polymerases and that are regulated differently in different stress situations. Furthermore, these ncRNAs are distributed at different locations in the cell, suggesting that they have different functions. In Study IV we showed the involvement of B‑WICH in RNA Pol III transcription and, as we previously had shown in Study I, that B‑WICH is able to create a more open chromatin structure, in this case by acting as a licensing factor for c-Myc and the Myc/Max/Mxd network. Taken together, we have revealed the mechanism by which the B‑WICH complex is able to regulate RNA Pol I and Pol III transcription and we have determined the role of NM1 in the B‑WICH complex. We conclude that B‑WICH is an important factor in the regulation of cell growth and proliferation. Furthermore, we found that the intergenic spacer of the rDNA gene is actively transcribed, producing ncRNAs. Different cellular locations suggest that the ncRNAs have different functions.

At the time of the doctoral defence the following papers were unpublished and had a status as follows: Paper 2: Manuscript; Paper 3: Manuscript

La concentration élevée de l'hPL dans la plasma de la femme enceinte, en fin de grossesse, sa sécrétion placentaire estimée à plus de 1 gramme par 24 heures, son pourcentage appréciabvle de l'ensemble des protgéines placentaires, sa structure composée d'une simple chaîne d'acides aminés, sans participation de résidus glycosylés ou phosphorylés, les inconnues actuelles concernant les mécanismes de régulation de sa production, sont les facteurs qui nous ont déterminé à réaliser sa synthèse in vitro

Thesis (Ph.D. in Molecular Biology) -- University of Colorado, 2006.
Typescript. Includes bibliographical references (leaves 126-147). Free to UCDHSC affiliates. Online version available via ProQuest Digital Dissertations;

DNA double-strand break (DSB) repair is essential for maintenance of genome stability. However, the compaction of the eukaryotic genome into chromatin creates an inherent barrier to any DNA-mediated event, such as during DNA repair. This demands that there be mechanisms to modify the chromatin structure and thus access DNA. Recent work has implicated a host of chromatin regulators in the DNA damage response and several functional roles have been defined. Yet the mechanisms that control their recruitment to DNA lesions, and their relationship with concurrent histone modifications, remain unclear. We find that efficient DSB recruitment of many yeast chromatin regulators is cell-cycle dependent. Furthering this, we find recruitment of the INO80, SWR-C, NuA4, SWI/SNF, and RSC enzymes is inhibited by the non-homologous end joining machinery, and that their recruitment is controlled by early steps of homologous recombination. Strikingly, we find no significant role for H2A.X phosphorylation (γH2AX) in the recruitment of chromatin regulators, but rather that their recruitment coincides with reduced levels of γH2AX. We go on to determine the chromatin remodeling enzyme Fun30 functions in histone dynamics surround a DSB, but does not significantly affect γH2AX dynamics. Additionally, we describe a conserved functional interaction among the chromatin remodeling enzyme, SWI/SNF, the NuA4 and Gcn5 histone acetyltransferases, and phosphorylation of histone H2A.X. Specifically, we find that the NuA4 and Gcn5 enzymes are both required for the robust recruitment of SWI/SNF to a DSB, which in turn promotes the phosphorylation of H2A.X.

DNA double-strand break (DSB) repair is essential for maintenance of genome stability. However, the compaction of the eukaryotic genome into chromatin creates an inherent barrier to any DNA-mediated event, such as during DNA repair. This demands that there be mechanisms to modify the chromatin structure and thus access DNA. Recent work has implicated a host of chromatin regulators in the DNA damage response and several functional roles have been defined. Yet the mechanisms that control their recruitment to DNA lesions, and their relationship with concurrent histone modifications, remain unclear. We find that efficient DSB recruitment of many yeast chromatin regulators is cell-cycle dependent. Furthering this, we find recruitment of the INO80, SWR-C, NuA4, SWI/SNF, and RSC enzymes is inhibited by the non-homologous end joining machinery, and that their recruitment is controlled by early steps of homologous recombination. Strikingly, we find no significant role for H2A.X phosphorylation (γH2AX) in the recruitment of chromatin regulators, but rather that their recruitment coincides with reduced levels of γH2AX. We go on to determine the chromatin remodeling enzyme Fun30 functions in histone dynamics surround a DSB, but does not significantly affect γH2AX dynamics. Additionally, we describe a conserved functional interaction among the chromatin remodeling enzyme, SWI/SNF, the NuA4 and Gcn5 histone acetyltransferases, and phosphorylation of histone H2A.X. Specifically, we find that the NuA4 and Gcn5 enzymes are both required for the robust recruitment of SWI/SNF to a DSB, which in turn promotes the phosphorylation of H2A.X.

The yeast SWI/SNF complex is the prototype of a subfamily of ATP-dependent chromatin remodeling complexes. It consists of eleven stoichiometric subunits including Swi2p/Snf2p, Swi1p, Snf5p, Swi3p, Swp82p, Swp73p, Arp7p, Arp9p, Snf6p, Snf11p, and Swp29p, with a molecular weight of 1.14 mega Daltons. Swi2p/Snf2p, the catalytic subunit of SWI/SNF, is evolutionally conserved from yeast to human cells. Genetic evidence suggests that SWI/SNF is required for the transcriptional regulation of a subset of genes, especially inducible genes. SWI/SNF can be recruited to target promotors by gene specific activators, and in some cases, SWI/SNF facilitates activator binding. Biochemical studies have demonstrated that purified SWI/SNF complex can hydrolyze ATP, and it can use the energy from ATP hydrolysis to generate superhelical torsion, mobilize mononucleosomes, enhance the accessibility of endonucleases to nucleosomal DNA, displace H2A/H2B dimers, induce dinucleosome and altosome formation, or evict nucleosomes. A human homolog of Swi2p/Snf2p, BRG1, is the catalytic subunit of the human SWI/SNF complex. Interestingly, isolated BRG1 alone is able to remodel a mononucleosome substrate. Importantly, mutations in mammalian SWI/SNF core subunits are implicated in tumorigenesis. Therefore, it remains interesting to characterize the role(s) of each subunit for SWI/SNF function. In this thesis project, I dissected SWI/SNF chromatin remodeling function by investigating the role of the SANT domain of the Swi3p subunit. Swi3p is one of the core components of SWI/SNF complex, and it contains an uncharacterized SANT domain that has been found in many chromatin regulatory proteins. Earlier studies suggested that the SANT domain of Ada2p may serve as the histone tail recognition module. For Swi3p, a small deletion of eleven amino acids from the SANT domain caused a growth phenotype similar to that of other swi/snf mutants. In chapter I, I have reviewed recent findings in the function of chromatin remodeling complexes and discuss the molecular mechanism of their action. In chapter II, I characterized the role of the SANT domain of Swi3p. I found that deletion of the SANT domain caused a defect in a genome-wide transcriptional profile, SWI/SNF recruitment, and more interestingly impairment of the SANT domain caused the dissociation of SWI/SNF into several subcomplexes: 1) Swi2p/Arp7p/Arp9p, 2) Swi3p/Swp73p/Snf6p, 3) Snf5p, and 4) Swi1p. Artificial tethering of SWI/SNF onto a LacZ reporter promoter failed to activate the reporter gene in the absence of the SANT domain, although Swi2p can be recruited to the LacZ promoter. We thus demonstrated that the Swi3p SANT domain is critical for Swi3p function and serves as a protein scaffold to integrate these subcomplexes into an intact SWI/SNF complex. In Chapter III, I first characterized the enzymatic activity of the subcomplexes, especially the minimal complex of Swi2p/Arp7p/Arp9p. We found that this minimal subcomplex is fully functional for chromatin remodeling in assays including cruciform formation, restriction enzyme accessibility in mononucleosomal and nucleosomal array substrates, and mononucleosome mobility shift. However, it is defective in ATP-dependent removal of H2A/H2B dimers. Moreover, we found that Swi3p and the N-terminal acidic domain of Swi3p strongly interact with GST-H2A and H2B but not GST-H3 or H4 tails. We purified a SWI/SNF mutant (SWI/SNF-Δ2N) that lacks 200 amino acids within the N-terminal acidic domain of Swi3p. Intriguingly, SWI/SNF-Δ2N failed to catalyze ATP-dependent dimer loss, although this mutant SWI/SNF contains all the subunits and has intact ATP-dependent activity in enhancing restriction enzyme accessibility. These data help to further understand the molecular mechanism of SWI/SNF, and show that H2A/H2B dimer loss is not an obligatory consequence of ATP-dependent DNA translocation, but requires the histone chaperone function of the Swi3p subunit. Based on these findings, we proposed a new model of the structural and functional organization of the SWI/SNF chromatin remodeling machinery: SWI/SNF contains at least four distinct modules that function at distinct stages of the chromatin remodeling process. 1) Swi1p and Snf5p modules directly interact with gene specific activators and function as the recruiter; 2) Swi2p/Arp7p/Arp9p generates energy from ATP hydrolysis and disrupts histone/DNA interactions; and 3) Swi3p/Swp73p/Snf6p may play dual roles by integrating each module into a large remodeling complex, as well as functioning as a histone H2A/H2B chaperone to remove dimers from remodeled nucleosomes. Chapter IV is a perspective from current work in this project. I first discuss the interest in further characterizing the essential role of Snf6p, based on its activation of LacZ reporter on its own. Using in vitro translated protein and co-IP studies, I tried to pinpoint the requirement of the SANT domain for SWI/SNF assembly. I found that Swi3p directly interacts with Swp73p, but not with other subunits. When Swi3p is first incubated with Swp73p, Swi3p also interacts with Snf6p, indicating that Swi3p indirectly interacts with Snf6p, therefore forming a subcomplex of Swi3p/Swp73p/Snf6p. This subcomplex can also be reconstituted using in vitro co-translation. Consistent with the TAP preparation of this subcomplex, partial deletion of the SANT domain of Swi3p does not affect the assembly of Swi3p/Swp73p/Snf6p in vitro. However, the assembly of SWI/SNF complex was not detected in the presence of eight essential in vitro translated subunits or from co-translation of all the subunits. I have discussed the interest in further characterizing the histone chaperone role of the Swi3p N-terminal acidic domain and the role of other core subunits of SWI/SNF such as Snf6p for transcriptional regulation.

Several aspects of Drosophila telomere biology indicate that telomere protection can be regulated by an epigenetic mechanism. First, terminally deleted chromosomes can be stably inherited and do not induce damage responses such as apoptosis or cell cycle arrest. Second, the telomere protection proteins HP1 and HOAP localize normally to these chromosomes and protect them from fusions. Third, unprotected telomeres still contain HeT-A sequences at sites of fusions. Taken together these observations support a model in which an epigenetic mechanism mediated by DNA damage response proteins protects Drosophilatelomeres from fusion. Work presented in this thesis demonstrates that the Drosophila proteins ATM and Nbs are required for the regulation of DNA damage responses similar to their yeast and mammalian counterparts. This work also establishes a role for the ATM and ATR DNA damage response pathways in the protection of both normal and terminally deleted chromosomes. Mutations that disrupt both pathways result in a severe telomere fusion phenotype, similar to HP1 and HOAP mutants. Consistent with this phenotype, HOAP localization at atm,atr double mutant telomeres is completely eliminated. Furthermore, telomeric sequences are still present, even at the sites of fusions. These results support a model in which an epigenetic mechanism mediated by DNA damage response proteins protects Drosophila telomeres from fusion.

Eukaryotic DNA is incorporated into the nucleoprotein structure of chromatin. This structure is essential for the proper storage, maintenance, regulation, and function of the genomes’ constituent genes and genomic sequences. Importantly, cells generate discrete types of chromatin that impart distinct properties on genomic loci; euchromatin is an open and active compartment of the genome, and heterochromatin is a restricted and inactive compartment. Heterochromatin serves many purposes in vivo, from heritably silencing key gene loci during embryonic development, to preventing aberrant DNA repeat recombination. Despite this generally repressive role, the DNA contained within heterochromatin must still be repaired and replicated, creating a need for regulated dynamic access into silent heterochromatin. In this work, we discover and characterize activities that the ATP-dependent chromatin remodeling enzyme SWI/SNF uses to disrupt repressive heterochromatin structure. First, we find two specific physical interactions between the SWI/SNF core subunit Swi2p and the heterochromatin structural protein Sir3p. We find that disrupting these physical interactions results in a SWI/SNF complex that can hydrolyze ATP and slide nucleosomes like normal, but is defective in its ability to evict Sir3p off of heterochromatin. In vivo, we find that this Sir3p eviction activity is required for proper DNA replication, and for establishment of silent chromatin, but not for SWI/SNF’s traditional roles in transcription. These data establish new roles for ATP-dependent chromatin remodeling in regulating heterochromatin. Second, we discover that SWI/SNF can disrupt heterochromatin structures that contain all three Sir proteins: Sir2p, Sir3p and Sir4p. This new disruption activity requires nucleosomal contacts that are essential for silent chromatin formation in vivo. We find that SWI/SNF evicts all three heterochromatin proteins off of chromatin. Surprisingly, we also find that the presence of Sir2p and Sir4p on chromatin stimulates SWI/SNF to evict histone proteins H2A and H2B from nucleosomes. Apart from discovering a new potential mechanism of heterochromatin dynamics, these data also establish a new paradigm of chromatin remodeling enzyme regulation by nonhistone proteins present on the substrate.

Eukaryotic DNA is incorporated into the nucleoprotein structure of chromatin. This structure is essential for the proper storage, maintenance, regulation, and function of the genomes’ constituent genes and genomic sequences. Importantly, cells generate discrete types of chromatin that impart distinct properties on genomic loci; euchromatin is an open and active compartment of the genome, and heterochromatin is a restricted and inactive compartment. Heterochromatin serves many purposes in vivo, from heritably silencing key gene loci during embryonic development, to preventing aberrant DNA repeat recombination. Despite this generally repressive role, the DNA contained within heterochromatin must still be repaired and replicated, creating a need for regulated dynamic access into silent heterochromatin. In this work, we discover and characterize activities that the ATP-dependent chromatin remodeling enzyme SWI/SNF uses to disrupt repressive heterochromatin structure. First, we find two specific physical interactions between the SWI/SNF core subunit Swi2p and the heterochromatin structural protein Sir3p. We find that disrupting these physical interactions results in a SWI/SNF complex that can hydrolyze ATP and slide nucleosomes like normal, but is defective in its ability to evict Sir3p off of heterochromatin. In vivo, we find that this Sir3p eviction activity is required for proper DNA replication, and for establishment of silent chromatin, but not for SWI/SNF’s traditional roles in transcription. These data establish new roles for ATP-dependent chromatin remodeling in regulating heterochromatin. Second, we discover that SWI/SNF can disrupt heterochromatin structures that contain all three Sir proteins: Sir2p, Sir3p and Sir4p. This new disruption activity requires nucleosomal contacts that are essential for silent chromatin formation in vivo. We find that SWI/SNF evicts all three heterochromatin proteins off of chromatin. Surprisingly, we also find that the presence of Sir2p and Sir4p on chromatin stimulates SWI/SNF to evict histone proteins H2A and H2B from nucleosomes. Apart from discovering a new potential mechanism of heterochromatin dynamics, these data also establish a new paradigm of chromatin remodeling enzyme regulation by nonhistone proteins present on the substrate.

In vivo DNA is compacted tightly, via its association with histones and non-histone proteins, into higher-order chromatin structure. In this state, the DNA is refractory to the cellular factors that require access to DNA. The repressive nature of chromatin is alleviated in part by the action enzymes that modify chromatin structure. There are two major groups of chromatin modifying enzymes: those that post-translationally modify histones by the addition of small chemical moieties and those that utilize the energy derived from ATP hydrolysis to physically disrupt chromatin structure. The SWI/SNF enzyme belongs to this latter group. The SWI/SNF complex was identified originally in yeast. Several of its subunits are required for the expression of a subset of inducible genes. The ATPase activity is provided by the SWI2/SNF2 protein. In mammals, there are two biochemically separable SWI/SNF complexes that contain either BRG1 or BRM, both homologs of yeast SWI2/SNF2. The yeast and mammalian SWI/SNF complexes are able to disrupt the Dnase I digestion pattern of in vitro assembled mononucleosomes and arrays, as well as facilitate the accessibility of restriction nucleases and transcription factors. The mechanism by which SWI/SNF functions has yet to be elucidated. SNF5 is a component of the yeast SWI/SNF complex. It is required for sucrose fermentation and mating type switching. The mammalian homolog of Snf5 is SNF5/INI1. SNF5/INI1 was identified simultaneously by two groups as a protein that shares homology with Snf5 and via a yeast two hybrid assay as a protein that interacts with HIV integrase (INtegrase Interactor). INI1 is a component of all mammalian SWI/SNF complexes purified to date. In humans, mutations and/or deletions in INI1 are associated with a variety of cancers, including malignant rhabdoid tumors, choroid plexus carcinomas, medullablastomas, primitive neuralectodermal tumors, and some cases of leukemia. Furthermore, constitutional mutations within INI1in individuals presenting with these tumors support the role of INI1 as a tumor suppressor. In this thesis, we show that Ini1 also functions as a tumor suppressor in mice. Approximately 20% of mice heterozygous for Ini1 present with tumors. Most of these tumors are undifferentiated or poorly differentiated sarcomas with variable rhabdoid features. All tumors examined to date show loss of heterozygosity at the Ini1 locus. We also show that Ini1 is essential for embryonic development. Mice homozygous-null for Ini1die between days 4 and 5.5 post-fertilization due to an inability to adhere to their substratum, form trophectoderm, and expand their inner cell mass. We further characterize the function of Ini1 in tumor suppression by generating mice heterozygous for both Ini1 and either Rb or p53. While heterozygosity at the Ini1 locus appears to have no effect on the rate of tumorigenesis in Rb-heterozygous mice, many of the tumors arising in compound heterozygous mice present with an altered morphology. This finding suggests that Ini1 may contribute to tumor progression due to loss of Rb. In contrast, mice compound heterozygous for Ini1 and p53 show a marked reduction in the rate of tumorigenesis compared to p53-heterozygous mice. Furthermore, the tumor spectrum is altered in these compound heterozygous mice. These findings suggest that Ini1 may function normally to repress p53 activity. Lastly, we show that expression of the Ini1 tumor suppressor itself is regulated tightly. Tissues and cells heterozygous for Ini1 express roughly equivalent levels of Ini1 protein and mRNA as their wild-type counterparts. We further show that this compensation is mediated by an increase in the rate of transcription from the wild-type Ini1 allele. Moreover, when exogenous Ini1 is introduced into Ini1-heterozygous cells, expression from the Ini1 promoter is reduced. These data indicate that a compensatory mechanism exists to ensure that the steady-state levels of Ini1 are constant. In summary, research detailed in this thesis has contributed to our understanding of the regulation of Ini1 as well as the role this protein plays in mammalian development and tumor suppression.

Non-Small Cell Lung Cancer (NSCLC), which accounts for 80% of all lung cancer cases, is associated with resistance to chemotherapy and poor prognosis. Exploitation of NSCLC-upregulated pathways that can either be targeted by novel therapeutics or used to improve the tumour-delivery of current chemotherapeutics are required. Among the matrix metalloproteinases (MMPs) that are essential for tumour development, MMP10 is a potential candidate as a therapeutic target based on its expression and contribution to NSCLC development. This research aims to explore the expression and functions of MMP10 in the tumour microenvironment of NSCLC and evaluate the potential of MMP10 as a target for therapeutic intervention. Herein, MMP10 expression at gene and protein levels were analysed in a panel of NSCLC cell lines using RT-PCR and Western blotting analysis. To determine MMP10 functional relevance, an in vitro angiogenesis assay using cell conditioned media was carried out. To identify specific peptide sequences for the design of prodrugs rationalised to be MMP10 activated, in vitro substrate cleavage studies were performed using a mass spectrometry approach to differentiate between MMP10 and the structurally similar MMP3. This study demonstrates that MMP10 is highly expressed in NSCLC and that high levels of MMP10 are associated with induction of angiogenesis, a crucial process supporting tumour growth. In addition to the achievement of having been able to differentiate between closely similar MMP3 and MMP10 through carefully monitoring the hydrolysis rate of compound 444259 (a known MMP substrate), data generated herein provides the basis for further studies to exploit MMP10 as a prodrug-activator.
Full text was made available at the end of the embargo period, 12th Dec 2019

Aus der Einleitung: "Spätestens seit dem Ersten Weltkrieg übte das Leitbild der Autarkie erheblichen Einfluss auf die deutsche Innovationskultur aus. Technikhistorische Interpreten sind sogar so weit gegangen, die Geburtsstunde einer spezifischen deutschen Ersatzstoffkultur in dieser Zeit zu verorten. Mit der Machtübernahme durch die Nationalsozialisten, spätestens aber mit Verkündigung des Vierjahresplanes 1936, der die deutsche Wirtschaft innerhalb von vier Jahren kriegsfähig machen sollte, intensivierten sich die Innovationsaktivitäten im Ersatzstoffbereich noch. Die dabei hervorgebrachten Surrogate können als direkte Resultate einer Autarkieorientierung der Volkswirtschaft betrachtet werden. Der auch in der frühen Bundesrepublik populäre Sachbuchautor Anton Zischka feierte die Forschungsleistungen, die Durchbrüche bei der Herstellung synthetischen Benzins mittels Kohlehydrierung, bei der Einführung von Zellwolle und künstlichem Kautschuk (Buna) sowie bei der Gewinnung neuer Kraftfuttermittel aus Holz und Kohle gebracht hatten, überschwänglich als Mittel zur Erlangung einer neuen Unabhängigkeit: „Und hervorgerufen oder ermöglicht durch diese Großtaten wurden hunderte, tausende Verbesserungen möglich, in einer gewaltigen Symphonie der Arbeit kam es zu einer Umwertung aller Werte, einer Revolution der Rohstoffwirtschaft, einer neuen Ära.“ Aufgrund ihrer Konsumentenferne ist anzunehmen, dass sich insbesondere in diktatorischen Innovationssystemen Ersatzstoffprojekte im sensiblen Lebensmittelbereich intensiver verfolgen ließen als unter Bedingungen eines freien Marktes mit selbstbewussten und mündigen Konsumenten. Zudem wirken zweifelsohne Kriege als Katalysatoren bei der Entwicklung von Ersatzstofftechnologien, nicht nur, weil in ihnen der freie, weltweite Warenaustausch bewusst oder als unbeabsichtigte Begleiterscheinung begrenzt wird, sondern auch, weil sie fast immer Zeiten von Knappheit und Hunger sind. [...]"

As depicted in Chapter I, 2-oxoglutarate- (2OG) dependent oxygenases are ubiquitous in living systems and display a wide range of cellular functions, spanning metabolism, transcription, and translation. Although functionally diverse, the 2OG oxygenases share a high degree of structural similarities between their catalytic sites. From a medicinal chemistry point of view, the combination of biological diversity and structural similarity presents a rather challenging task for the development of selective small molecules for functional studies in vivo. The non-selective metal chelator 8-hydroxyquinoline (8HQ) was used as a template for the generation of tool compound I for the KDM4 subfamily of histone demethylases via application of the Betti reaction. Structural analogue II was used as the corresponding negative control (Figure A). These compounds were characterised in vitro against a range of 2OG oxygenases and subsequently used for studies in cells. I displays selectivity for KDM4 and increases the level of the H3K9me3 histone mark in cells. It has an effect on the post-translational modification pattern of histone H3, but not other histones, and reduces the viability of lung cancer cells, but not normal lung cells, derived from the same patient. I also stabilises hypoxia-inducable factor HIF in cells via a mechanism which seems to be independent from prolyl hydroxylase inhibition. This work is described in Chapters II and III. The chemical biology research in epigenetics is complemented by qualitative analysis conducted in the social sciences at Said Business School. With a global view on how innovation occurs and may actively be fostered, Chapter IV focuses on the potential of epigenetics in drug discovery and how this process may actively be promoted within the framework of open innovation. Areas of focus include considerations of incremental and disruptive technology; how to claim, demarcate, and control the market; how knowledge brokering occurs; and insights about process, management, organisation, and culture of open innovation. In contrast to the open-skies approach adopted for the development of a tool compound in Chapters II and III, a focused-library approach was taken for the generation of a tool compound for the OGFOD1 ribosomal prolyl hydroxylase. The development of a suitable in vitro activity assay for OGFOD1 in Chapter V enabled the development of lead compound III in Chapter VI. III is selective for OGFOD1 against the structurally closely related prolyl hydroxylase PHD2.

碩士
元智大學
生物與醫學資訊碩士學位學程
99
Protein acetylation, which is catalyzed by acetyltransferases, is a type of post-translational modification and crucial to numerous essential biological processes, including transcriptional regulation, apoptosis, and cytokine signaling. As the experimental identification of protein acetylation sites is time consuming and laboratory intensive, several computational approaches have been developed for identifying the candidates of experimental validation. In this work, we attempt to investigate the substrate site specificities of acetylated lysine on histone and non-histone proteins. Maximal dependence decomposition (MDD) is employed to cluster a large set of acetylation data into subgroups containing significantly conserved motifs. In order to consider the biochemical property of amino acids when doing MDD, we categorize the twenty types of amino acids into five groups such as neutral, acid, basic, aromatic, and imino groups. Herein, support vector machine (SVM) was applied to learn the computational models with combinations of amino acid pair composition and BLOSUM62 matrix of proteins. According to the five-fold cross-validation, the proposed method could reach the predictive accuracies of 77.2% and 89.1% on histone and non-histone proteins, respectively. To help biologists investigating lysine acetylation on the uncharacterized proteins, a web-based system is constructed and is freely available at http://csb.cse.yzu.edu.tw/AceK/.

In this study, the role of histone-like proteins in gene regulation in uropathogenic Escherichia coli isolate 536 was monitored. The histone-like nucleoid structuring protein H-NS is a global regulator in Escherichia coli that has been intensively studied in non-pathogenic strains. No comprehensive study on the role of H-NS and it’s homolog StpA on gene expression in a pathogenic E. coli strain has been carried out so far. Moreover, we identified a third, so far uncharacterized member of the H-NS-like protein family in uropathogenic E. coli isolate 536, which was designated Hlp (H-NS-like protein). Hlp is a 134-amino acid protein, which shares 58 % sequence identity with H-NS. The gene coding for the Hlp protein, hlp, is found in several uropathogenic E. coli variants, but not in non-pathogenic E. coli K-12. In UPEC strains 536 and CFT073, Hlp is encoded on a possibly horizontally acquired 23-kb genomic region inserted into the serU locus. Studies on hlp transcription revealed, that the gene is transcribed monocistronically from a single promoter and that expression is repressed by H-NS. Purified Hlp protein was binding to its own and to the hns promoter, thereby mediating negative auto- and crossregulation. Furthermore, Hlp and H-NS were directly interacting, resulting in the formation of stable heteromers. Complementation studies with hns mutant strains in a K-12 background revealed that the Hlp protein had in vivo activity, being able to complement the lack of H-NS in terms of motility, growth, and repression of the proU, bgl, and clyA genes. When analyzing the role of the histone-like proteins in expression of virulence-associated genes by using DNA arrays and classical phenotypic assays, most of the observed effects were mediated by the H-NS protein alone. Expression profiling revealed that transcript level of more than 500 genes was affected by an hns mutation, resulting in increased expression of alpha-hemolysin, fimbriae and iron-uptake systems, as well as genes involved in stress adaptation. Furthermore, several other putative virulence factors were found to be part of the H-NS regulon. On the other hand, no effect of StpA alone was observed. An hns stpA double mutant, however, exhibited a distinct gene expression pattern that differed in great parts from that of the hns single mutant. This suggests a direct interaction between the two homologs and the existence of distinct regulons of H-NS and an H-NS/StpA heteromeric complex. Although the H-NS protein has – either as homomer or in complex with StpA – a marked impact on gene expression in pathogenic E. coli strains, its effect on urovirulence is ambiguous. At a high infection dose, hns mutants accelerate lethality in murine UTI and sepsis models relative to the wild type, probably due to increased production of alpha-hemolysin. At lower infectious dose, however, mutants lacking H-NS are attenuated through their impaired growth rate, which can only partially be compensated by the higher expression of numerous virulence factors. As seen with StpA, an hlp single mutant did not exhibit a notable phenotype under standard growth conditions. A severe growth defect of hns hlp double mutants at low temperatures, however, suggests a biological relevance of H-NS/Hlp heteromers under certain circumstances. Furthermore, these mutants expressed more capsular polysaccharide and curli fimbriae, thereby indicating a distinct role of H-NS and Hlp in regulation of these surface structures. The H-NS paralogs Hlp and StpA also modulated H-NS-mediated regulation of fimbrial adhesins, and are oppositely required for normal growth at low or high temperatures, respectively. Finally, expression levels of the three histone-like proteins H-NS, StpA and Hlp itself varied with different temperatures, thereby suggesting a flexible composition of the nucleoid-associated protein pool. Hence, we propose that the biological role of Hlp and StpA does not rely on a distinct function of the single protein, but rather on their interaction with the global regulator H-NS
In dieser Studie wurde die Rolle von Histon-ähnlichen Proteinen bei der Genregulation im uropathogenen Escherichia coli (UPEC) Isolat 536 untersucht. Das Histon-ähnliche Protein H-NS (engl. histone-like nucleoid structuring protein) ist ein globaler Regulator in E. coli, der in apathogenen Stämmen eingehend untersucht worden ist. Im Gegensatz dazu liegen noch keine umfassenden Studien zur Rolle von H-NS und des homologen Proteins StpA in einem pathogenen E. coli Stamm vor. Zudem konnten wir ein drittes, bis jetzt noch nicht charakterisiertes Mitglied der Familie von H-NS-ähnlichen Protein im uropathogenen E. coli Isolat 536 identifizieren, das Hlp benannt wurde (für H-NS-like protein). Hlp ist ein aus 134 Aminosäuren bestehendes Protein, dessen Sequenz zu 58 % identisch mit der des H-NS Proteins ist. Das Gen, das für das Hlp Protein kodiert, hlp, konnte in zahlreichen uropathogenen und Fäkalisolaten nachgewiesen werden, jedoch nicht im apathogenen E. coli K-12. In den UPEC Isolaten 536 und CFT073 ist das hlp Gen auf einer 23-kb großen genomischen Insel lokalisiert, die in den serU Lokus inseriert ist und möglicherweise über horizontalen Gentransfer erworben wurde. Untersuchungen zur Transkription des hlp Gens ergaben, dass das Gen monocistronisch von einem einzigen Promotor transkribiert, und dessen Expression durch H-NS reprimiert wird. Rekombinantes Hlp Protein war befähigt, sowohl an seinen eigenen, als auch an den hns Promotor zu binden, was zu negativer Auto- und Kreuzregulation führte. Zudem konnte gezeigt werden, dass Hlp und H-NS direkt miteinander interagieren, was zu stabilen Heteromeren führte. Komplementierungsstudien in hns Mutanten einiger K-12 Stämme ergaben, dass das Hlp Protein über in vivo Aktivität verfügt, was es befähigte, die Abwesenheit von H-NS bei zahlreichen Phänotypen wie z.B. Motilität, Wachstum, und Repression der proU, bgl und clyA Gene zu komplementieren. Die Rolle der Histon-ähnlichen Proteine bei der Expression von Virulenz-assoziierten Genen wurde mittels DNA Array Technologie, sowie klassischen phänotypischen Tests analysiert. Dabei wurden die meisten der beobachteten Effekte einzig durch das H-NS Protein bedingt. Die Expressionsstudien ergaben, dass über 500 Gene von einer hns Mutation beeinflusst wurden, was eine verstärkte Expression des alpha-Hämolysins, mehrerer Fimbrien und Eisenaufnahmesysteme sowie von Genen, die in Stress-Antworten involviert sind, bedingte. Des Weiteren konnten zahlreiche putative Virulenzfaktoren dem H-NS-Regulon zugeordnet werden. Andererseits konnten keine Effekt durch StpA beobachtet werden. Eine hns stpA Doppelmutante wies jedoch ein eindeutiges Expressionsmuster auf, das in großen Teilen von dem der hns Einzelmutante abwich. Dies legt nahe, dass beide Proteine direkt miteinander interagieren, was das Auftreten von unterschiedlichen Regulons zur Folge hat, die entweder durch H-NS oder einem heteromeren H-NS/StpA Komplex beeinflusst werden. Obwohl das H-NS Protein – entweder als Homomer oder als Komplex mit StpA – einen sehr starken Einfluss auf die Genexpression pathogener E. coli Stämme nimmt, bleiben dessen Effekte auf die tatsächliche Virulenz im Urogenitaltrakt unklar. In einem experimentellen Mausmodell der aufsteigenden Harnwegsinfektion bewirken hns Mutanten, in hoher Dosis verabreicht, eine rasch eintretende Lethalität, was vermutlich der verstärkten Produktion von alpha-Hämolysin zuzuschreiben ist. In verringerter Dosis verabreicht, sind diese Mutanten durch ihre langsameren Wachstumsraten jedoch attenuiert, was nur teilweise durch die vestärkte Expression zahlreicher Virulenzfaktoren kompensiert werden kann. Wie schon bei StpA beobachtet, besitzt eine hlp Mutante keinen offensichtlichen Phänotyp, zumindest unter Standard-Wachstumsbedingungen. Jedoch macht sich in hns hlp Doppelmutanten ein starker Wachstumsdefekt bei erniedrigten Temperaturen bemerkbar, was eine biologische Relevanz von H-NS/Hlp Heteromeren unter bestimmten Bedingungen nahe legt. Des Weiteren exprimierten diese Mutanten erhöhte Mengen an Kapsel-Polysacchariden und Curli-Adhesin, was als Indiz für eine besondere Rolle für H NS und Hlp bei der Regulation dieser Oberflächenstrukturen dienen kann. Zudem hatten beide H-NS-Paraloge Hlp und StpA einen modulierenden Effekt bei der H-NS-vermittelten Regulation weiterer Fimbrien-Adhesine und waren in gegenläufigen Maßen für normales Wachstum bei erhöhten bzw. erniedrigten Temperaturen notwendig. Zuletzt variierte das Expressionsniveau der drei Histon-ähnlichen Proteine H-NS, StpA und Hlp bei unterschiedlichen Temperaturen, was auf eine flexible Zusammensetzung verfügbarer Nucleoid-assoziierter Proteine hindeutet. Dies alles impliziert, dass die biologische Relevanz von Hlp, und StpA gleichermaßen, nicht auf gesonderten Funktionen des einzelnen Proteins beruht, sondern vielmehr auf deren Interaktionen mit dem globalen Regulatorprotein H-NS

In maligne transformierten Zellen fördert die kurzkettige Fettsäure Butyrat Differenzierung, induziert Apoptose und hemmt Proliferation. Dabei moduliert Butyrat die Expression von verschiedenen Zellzyklus- und Apoptoseregulatoren. Wie Butyrat seine Wirkungen auf chromosomaler Ebene vermittelt, ist bisher nicht ausreichend geklärt. Bekannt ist, dass Butyrat Histondeacetylasen nichtkompetetiv hemmt und durch Hyperacetylierung von nukleären Histonproteinen die Chromatinstruktur moduliert. Die „high-mobility-group“ (HMG) Proteine sind neben Histon-Proteinen strukturelle Bestandteile des Chromatins. Die vermehrte Expression des HMGA1-Proteins ist eine Gemeinsamkeit vieler humaner Malignome und die HMGA1-Proteinfamilie wurde selbst als neue Gruppe von Onkogenen erkannt. Die HMGA1 Proteine beeinflussen die Expression zahlreicher Gene und stehen selbst wiederum unter der Kontrolle von Onkogenen, wie z.B. dem c-myc. Im Rahmen dieser Arbeit konnte gezeigt werden, dass Butyrat und der Histon-deacetylase-Inhibitor Trichostatin A die Expression von HMGA1 in humanen Adenokarzinomzellen des Gastrointestinaltraktes modulieren. Butyrat-Konzentrationen von 2mM und 4mM führten erstmals nach 24-stündiger Inkubation zu einer deutlichen Reduktion der mRNA-Expression von HMGA1. In der Magenkarzinomzelllinie 23132/87 und der Kolonkarzinomzelllinie Sw-480 wird die HMGA1 mRNA Expression durch Butyrat zeit- und dosisabhängig reduziert. In der Kolonkarzinomzelllinie Sw-620 konnte für die untersuchten Konzentrationen keine Dosisabhängigkeit festgestellt werden. Auch Trichostatin A bewirkt eine Reduktion der mRNA-Expression von HMGA1 in den untersuchten Zelllinien. Wie Butyrat die Expression von HMGA1 moduliert, ist nicht geklärt. Denkbar ist, dass Butyrat über Modulation vorgeschalteter Signalkaskaden, wie z.B. im Falle des c-myc, die HMGA1-Expression beeinflusst. Aber auch über eine Modulation der Chromatinstruktur durch Hemmung der Histondeacetylasen mit nachfolgenden Veränderungen der Expression verschiedener Gene könnte Butyrat die Expression von HMGA1 beeinflussen. Da die gleiche Wirkung auf die HMGA1-Expression durch den spezifischen Histondeacetylase-Inhibitor Trichostatin A vermittelt wird, könnte die Hemmung dieser Enzyme der Mechanismus sein, über den Butyrat seine Wirkungen ausübt. In vitro- und in vivo- Untersuchungen zeigen, dass eine Hemmung der HMGA1-Proteinsynthese die maligne Transformation verhindern, das metastatische Potential verringern und sogar das Wachstum bereits existenter Tumoren verlangsamen kann. Der protektive Effekt von Butyrat hinsichtlich der malignen Transformation und die Wirkung von Butyrat auf bereits maligne transformierte Zellen könnten zumindest teilweise dadurch erklärt werden, dass Butyrat die Expression von HMGA1 in Tumorzellen reduziert und damit dessen malignes Potential vermindert. Auch die Nicht-Histon-Proteine HMGN1 und HMGN2 stellen wichtige strukturelle Elemente des Chromatins dar. Sie werden sowohl in Normalgewebe als auch in maligne transformierten Zellen exprimiert. Auch die untersuchten Zelllinien Sw-480, Sw-620 und 23132/87 exprimieren HMGN1 und HMGN2. Signifikante Unterschiede zwischen der Primärtumorzelllinie Sw-480 und der Metastasenzelllinie Sw-620 des Sw-480 Kolonkarzinoms waren nicht feststellbar. Sowohl Butyrat als auch Trichostatin A senken in den untersuchten Karzinomzelllinien die Expression von HMGN1- bzw. HMGN2-mRNA, wobei dieser Effekt teilweise zeit- und dosisabhängig ist. Da die gleiche Wirkung auf die Expression von HMGN1 und HMGN2 durch den spezifischen Histondeacetylase-Inhibitor Trichostatin A vermittelt wird, könnte die Hemmung der Histondeacetylasen auch in diesem Fall der Mechanismus sein, über den Butyrat seine Wirkungen ausübt. Es gibt zunehmend Hinweise, dass HMGN1 und HMGN2 und die Modulation ihrer Expression eine bedeutende Rolle bei der Regulation zellulärer Vorgänge, wie z.B. Transkription und Replikation, haben. Nachdem in den letzten Jahren gezeigt wurde, welche Bedeutung Veränderungen der Chromatinstruktur durch Modifikation der Histonproteine für die Karzinogenese haben, ist zu vermuten, dass auch die Modulation der Chromatinbestandteile HMGN1 und HMGN2 in diesem Zusammenhang von Bedeutung sein könnte. Über die Bedeutung der HMGN-Expression, deren Modulation bzw. die der posttranslationalen Modifikation in humanen Karzinomen ist bis jetzt wenig bekannt. Von Bedeutung könnte dabei z.B. die kürzlich nachgewiesene Butyrat-induzierte Hyperacetylierung von HMGN2 sein. Unklar ist noch das unterschiedliche Ausmaß der Acetylierung der HMGN-Proteine in verschieden differenzierten Karzinomen, der Vergleich zwischen Normalgewebe und maligne transformierten Zellen und die Dynamik der Acetylierung in der Tumorprogression. Denkbar ist, dass zumindest ein Teil der bekannten Wirkungen von Butyrat auf einer Modulation dieser Chromatinbestandteile mit nachfolgend veränderter Genexpression beruht
Butyrate, a short-chain-fatty-acid (SCFA), is generated by anaerobic fermentation of undigested carbohydrates within the colon. In human carcinoma cells butyrate causes apoptosis, differentiation and growth inhibition. The molecular mechanisms by which butyrate mediates its effects are not yet fully understood. The family of non-histone nuclear proteins (high-mobility-group (HMG) proteins) is divided into three subfamilies, HMG-B, HMG-A and HMG-N, respectively. HMG-N proteins bind to chromatin and induce structural changes that affect DNA-dependent activities, such as transcription and replication. The HMG-A proteins are involved in gene expression during development and immune response. In normal epithelial cells HMG-A protein expression is low, however, HMG-A is overexpressed in several human carcinomas. In this study we examined the effects of butyrate on HMG protein expression in human gastrointestinal carcinoma cells. Treatment of human gastrointestinal carcinoma cells with butyrate and Trichostatine A led to a significant reduction of HMG-mRNA levels. The effect was observed in all examined cell lines, independent of origin or degree of differentiation. Butyrate mediates a wide range of effects in vitro and in vivo, such as inhibition of colon carcinogenesis and induction of apoptosis and differentiation. Modulation of the expression of transcription factors as well as the induction of changes within chromatin structure and composition are potential pathways of butyrate action. Butyrate is known to induce acetylation of core histones and non-histone nuclear proteins. Alterations of the chromatin structure caused by histone hyperacetylation or deacetylation may play an important role in changes of gene expression patterns and may consequently promote cancerogenesis. Modulation of HMG-mRNA expression constitutes an additional step in the modification of the chromatin structure. Therefore, it may at least in part be responsible for the wide range of butyrate associated effects